2 completed. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Barr Laboratories: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Early Aggressive Rheumatoid Arthritis (TEAR) methotrexate, sulfasalazine, hydroxychloroquine - Rheumatoid Arthritis | Phase 4 | Completed | University of Alabama at Birmingham | 755 | 2004-05-01 | 2014-07-17 |
| Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer cyproterone acetate, quality-of-life assessment - Hot Flashes, Prostate Cancer | Phase 3 | Completed | Barr Laboratories | 1999-12-01 | 2013-03-26 |
Arthralgia (1) · Arthritis, Rheumatoid (1) · Hot Flashes (1) · Prostatic Neoplasms (1)
Cyproterone Acetate (1) · Etanercept (1) · Hydroxychloroquine (1) · Methotrexate (1) · Sulfasalazine (1)
United States (2)
Jeffrey Curtis, MD (1) · Ronald W. Lewis, MD (1)
PMID 22508468, PMID 22730343, PMID 26606398, PMID 27188329, PMID 27483410